Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier W Sanders

Showing results (1-10 of 325) with videos related to

Pageof 33
Sort By:
Expert Review of Vaccines|August 23, 2011
Clinical evaluation of a soluble trimeric HIV-1 envelope glycoprotein vaccineRogier W Sanders
BMC Biology|December 11, 2012
HIV takes double hit before entryRogier W Sanders
Antiviral Research|April 26, 2011
Molecular strategies to design an escape-proof antiviral therapyBen Berkhout, Rogier W Sanders
Journal of the International AIDS Society|November 22, 2021
Structure-guided envelope trimer design in HIV-1 vaccine development: a narrative reviewRonald Derking, Rogier W Sanders
Expert Review of Vaccines|December 15, 2015
HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodiesKwinten Sliepen, Rogier W Sanders
Current Pharmaceutical Design|December 7, 2010
Sealing the envelope - the HIV-1 envelope glycoproteins as targets for therapeutics and vaccinesRogier W Sanders, Ben Berkhout
Expert Opinion on Biological Therapy|July 19, 2012
Gene therapy as a vaccine for HIV-1Ben Berkhout, Rogier W Sanders
Nature|October 9, 2014
HIV: A stamp on the envelopeRogier W Sanders, John P Moore
Expert Review of Vaccines|November 27, 2012
Optimizing cellular immunity against HIV-1 Gag and preventing suppression by HIV-1 gp120Thijs van Montfort, Rogier W Sanders
Immunological Reviews|January 31, 2017
Native-like Env trimers as a platform for HIV-1 vaccine designRogier W Sanders, John P Moore
Pageof 33

Showing results (1-10 of 325) with videos related to

Sort By:
Pageof 33
Expert Review of Vaccines|August 23, 2011
Clinical evaluation of a soluble trimeric HIV-1 envelope glycoprotein vaccineRogier W Sanders
BMC Biology|December 11, 2012
HIV takes double hit before entryRogier W Sanders
Antiviral Research|April 26, 2011
Molecular strategies to design an escape-proof antiviral therapyBen Berkhout, Rogier W Sanders
Journal of the International AIDS Society|November 22, 2021
Structure-guided envelope trimer design in HIV-1 vaccine development: a narrative reviewRonald Derking, Rogier W Sanders
Expert Review of Vaccines|December 15, 2015
HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodiesKwinten Sliepen, Rogier W Sanders
Current Pharmaceutical Design|December 7, 2010
Sealing the envelope - the HIV-1 envelope glycoproteins as targets for therapeutics and vaccinesRogier W Sanders, Ben Berkhout
Expert Opinion on Biological Therapy|July 19, 2012
Gene therapy as a vaccine for HIV-1Ben Berkhout, Rogier W Sanders
Nature|October 9, 2014
HIV: A stamp on the envelopeRogier W Sanders, John P Moore
Expert Review of Vaccines|November 27, 2012
Optimizing cellular immunity against HIV-1 Gag and preventing suppression by HIV-1 gp120Thijs van Montfort, Rogier W Sanders
Immunological Reviews|January 31, 2017
Native-like Env trimers as a platform for HIV-1 vaccine designRogier W Sanders, John P Moore
Pageof 33